BIONEXUS GENE LAB CORP COM
BIONEXUS GENE LAB CORP COM is a security (CUSIP 090628306) tracked across SEC portfolio filings. 4 institutional managers reported $499 on Form 13F as of 2026-06-30; 1 registered fund positions totaling $6 via N-PORT as of 2026-03-31.
Summary
- Issuer: BIONEXUS GENE LAB CORP
- Class: COM
- CUSIP: 090628306
- Asset category: EC
- 13F holders: 4
- 13F value: $499
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $6
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| UBS Group AG | Zurich, V8 | $495 | 231 |
| Caitong International Asset Management Co., Ltd | HONG KONG, K3 | $2 | 1 |
| WELLS FARGO & COMPANY/MN | SAN FRANCISCO, CA | $2 | 1 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |
Top fund holders (N-PORT)
More